In the context of rTCR-T cells, it was found that co-expression of CXCR2 with MAGE-A3 specific TCRs could significantly enhance migration to the tumor site in a mice model of melanoma, resulting in reduced tumor growth [93]. The gene discussed is CXCR2; the disease is neoplasm.